Kannalife

About:

Kannalife is a biopharmaceutical company that focuses on innovation in research and development of novel cannabinoid therapeutic agents.

Website: http://www.kannalife.com

Twitter/X: kannalife

Top Investors: Michael J. Fox Foundation, National Institute of Neurological Disorders and Stroke, Medical Marijuana Inc., CannaVest

Description:

Kannalife, a subsidiary of Neuropathix, Inc (OTCQB: NPTX), is a biopharmaceutical company focused on discovering, developing, and commercializing a product platform of novel molecules from our proprietary next-generation cannabinoid therapeutics as potent, non-opioid alternatives to treat patients with a variety of unmet medical needs.